 |
Conference papers
A new target for therapy: the ERK pathway regulates IL-10 production in autoreactive CD5+B lymphocytes.
Yves Renaudineau
1, 2
Jacques-Olivier Pers
1
Rizgar A Mageed
3
Soizic Garaud
1
Christelle Le Dantec
1
Christophe Jamin
2, 1
Pierre Youinou
1, 2
Yves Renaudineau 1, 2
Author IdHAL : yves-renaudineau ORCID : https://orcid.org/0000-0001-5098-5002 ISNI : http://isni.org/isni/0000000140911982
Jacques-Olivier Pers 1
Author
Rizgar A Mageed 3
Author
Soizic Garaud 1
Author
Christelle Le Dantec 1
Author
Christophe Jamin 2, 1
Author IdHAL : christophe-jamin
Pierre Youinou 1, 2
Author
1
EA2216 - Immunologie et Pathologie (CHU Morvan, 5 Rue Foch, BP 824, 29609 Brest - France)
- UBO - Université de Brest : EA2216 (Université de Bretagne Occidentale - 3 Rue des Archives 29238, Brest - France)
- IFR148 (France)
2
Laboratoire d'Immunologie et Immunothérapie (France)
3
William Harvey Research Institute, Barts and the London Medical School (Charterhouse Square, London EC 1M 6BQ - United Kingdom)
Document type :
Conference papers
Domain :
Complete list of metadatas
https://hal.univ-brest.fr/hal-00778854
Contributor : Geneviève Michel <>
Submitted on : Monday, January 21, 2013 - 3:09:52 PM
Last modification on : Wednesday, November 29, 2017 - 2:53:51 PM
Contributor : Geneviève Michel <>
Submitted on : Monday, January 21, 2013 - 3:09:52 PM
Last modification on : Wednesday, November 29, 2017 - 2:53:51 PM
Identifiers
- HAL Id : hal-00778854, version 1
Collections
Citation
Yves Renaudineau, Jacques-Olivier Pers, Rizgar A Mageed, Soizic Garaud, Christelle Le Dantec, et al.. A new target for therapy: the ERK pathway regulates IL-10 production in autoreactive CD5+B lymphocytes.. 8th European Lupus Meeting, Apr 2011, Porto, Portugal. Vol 20, 4, p221. ⟨hal-00778854⟩
Metrics
Record views